Avalo Therapeutics (AVTX) closed at $7.32 on November 2, 2026, up 2.1% from the previous close, on volume of 1,528,111 shares (30-day average 2,112,469).
Data as of November 2, 2026.
2-Nov-2026
Avalo Therapeutics (AVTX) Gets a Buy from BTIG
TipRanks (Mon, 2-Nov 9:43 PM ET)
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire (Mon, 2-Nov 4:00 PM ET)
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Tue, 29-Sep 4:01 PM ET)
Globe Newswire (Wed, 23-Sep 7:00 AM ET)
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
Globe Newswire (Thu, 6-Aug 7:00 AM ET)
Market Chameleon (Wed, 6-May 5:54 AM ET)
Market Chameleon (Wed, 6-May 3:05 AM ET)
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Avalo Therapeutics trades on the NASDAQ stock market under the symbol AVTX.
As of November 2, 2026, AVTX stock price climbed to $7.32 with 1,528,111 million shares trading.
AVTX has a beta of 1.86, meaning it tends to be more sensitive to market movements. AVTX has a correlation of 0.05 to the broad based SPY ETF.
AVTX has a market cap of $392.57 million. This is considered a Small Cap stock.
In the last 3 years, AVTX traded as high as $34.46 and as low as $3.39.
The top ETF exchange traded funds that AVTX belongs to (by Net Assets): VTI, XBI, IWM, VXF, VTWO.
AVTX has underperformed the market in the last year with a price return of -59.4% while the SPY ETF gained +11.7%. AVTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -62.2% and -35.0%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
AVTX support price is $6.79 and resistance is $7.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTX shares will trade within this expected range on the day.
